Cargando…
HIV/AIDS and the nervous system /
This volume provides a comprehensive understanding of HIV/AIDS and neuro-AIDS, including a history of the disease, and an explanation of many of the conditions that can arise in afflicted patients, including opportunistic infections, central nervous system tumors, spinal cord disorders, myopathies a...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Edinburgh :
Elsevier,
2007.
|
| Colección: | Handbook of clinical neurology ;
3rd ser., v. 85. |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo |
Tabla de Contenidos:
- Front Cover; Handbook of Clinical Neurology; HIV/Aids and the Nervous System; Copyright Page; Handbook of Clinical Neurology 3rd Series; Foreword; List of contributors; Contents; Chapter 1: Introduction to HIV infection and neuro-AIDS; 1.1. The epidemic in 2006; 1.2. Neuro-AIDS in 1985 and 2005; 1.3. What have we learned from HIV and its interaction with the nervous system?; Chapter 2: Neuroepidemiology of HIV/AIDS; 2.1.1. The origin of HIV; 2.1.3. Case definition; 2.1.4. Mode and trend of transmission of HIV; 2.1.5. Natural history of HIV infection; 2.1.6. The HAART era
- 2.2. Epidemiology of neurological complications of HIV infection2.2.2. Occurrence of HIV-D; 2.2.3. Progressive encephalopathy of childhood; 2.2.4. HIV-associated central nervous system lymphoma; 2.2.5. HIV and stroke risk; 2.2.6. HIV myelopathy; 2.2.8. HIV neuropathy; 2.2.9. HIV-related skeletal muscle disorders; 2.3.1. Bacteria; 2.3.2. Fungi; 2.3.3. Viruses; 2.3.4. Parasites; References; Chapter 3: HIV neurology in the developing world; 3.2. Diagnostic limitations in developing countries; 3.4.5. Less common infections (CMV, PCNSL, NHL, progressive multifocal leucoencephalopathy)
- 3.5. Pediatric HIV neurology3.6. Special issues in tropical settings; Chapter 4: The neuropathogenesis of HIV-1 infection; 4.2. Epidemiology of HAD in the era of HAART; 4.8. Prognostic biomarkers for HAD; 4.9. Future prospects for the neuropathogenesis of HIV-1 infection; Chapter 5: Neurological sequelae of primary HIV infection; 5.1. Introduction; 5.2. Epidemiology; 5.10. Investigations; 5.11. Pathogenesis; 5.12. Treatment; Chapter 6: AIDS dementia complex; 6.5.4. Neurophysiological investigations; 6.7. Pathogenesis; 6.8. Management; 6.8.3. Palliative management
- Chapter 7: Neurocognitive assessment of persons with HIV disease7.2. General intellectual abilities; 7.4. Tests of specific ability areas; 7.4.1. Attention and speed of information processing; Further Reading; Chapter 8: HIV myelopathy; 8.2. Pathology; 8.4. Clinical manifestations; Chapter 9: Peripheral neuropathy in HIV infection; 9.2. Types of HIV neuropathy; 9.2.2. Toxic neuropathy; 9.4. Mononeuropathy multiplex; Chapter 10: Myopathy in HIV infection; 10.2. Epidemiology; 10.4. Laboratory studies; 10.6.2. Antiretroviral-related myopathy; Chapter 11: Cerebral toxoplasmosis in AIDS
- 11.2. The parasite11.4. Pathogenesis and pathology; 11.6.2. Imaging; 11.7. Treatment; Chapter 12: Cryptococcal infection; 12.2. Microbiology; 12.4. Pathogenesis; 12.7. Prognostic indicators; Chapter 13: Progressive multifocal leukoencephalopathy; 13.2. Molecular biology of JC virus; 13.4. Epidemiology of JC virus; 13.7. Clinical disease; Chapter 14: Other opportunistic infections of the central nervous system in AIDS; 14.1.2. Atypical mycobacteria; 14.2. Viral opportunistic infections; 14.2.1. Cytomegalovirus; 14.4. Parasitic infections; Chapter 15: Primary central nervous system lymphoma